Tempest Therapeutics, Inc. (TPST)
$0.76-1.30%Close
SELLCRISIS · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- -1.71
- P/E (TTM)
- -0.18
- Short % float
- 14.62%
- Days to cover
- 1.0
- SI change
- +73.6%
- 1W
- -6.17%
- 1M
- -5.00%
- vs SPY 1W
- -7.33%
- vs SPY 1M
- -7.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TPST?
- LOPJLB’s latest quantitative signal on Tempest Therapeutics, Inc. (TPST) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TPST in?
- Tempest Therapeutics, Inc. (TPST) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Tempest Therapeutics, Inc. (TPST) do?
- Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial …